Biosensors   

Is Biosensors a good buy?

come come..!! let me take a look.. 

 

Atlantis had reduced its holding  by 51m shares (7.61 to 4.61%)  due to  the following reason:

Atlantis Investment Management (Hong Kong) Limited's discretionary authority to manage an account on behalf of a client has been withdrawn by that client.

 

starlene      ( Date: 01-Nov-2013 22:56) Posted: Who is elling or buying Biosensor,,,my laptop can't open..some kind soul can help..thks a million   http://infopub.sgx.com/FileOpen/FORM3_Atlantis_29Oct13.ashx?App=Announcement& FileID=262344  New123      ( Date: 01-Nov-2013 20:17) Posted: BioFreedom? Continues to Demonstrate Comparable Long - Term Safety and Efficacy to Conventional DES   BioFreedom is in the process of being launched in selected markets, with a full commercial launch anticipated during 2014.   hopefully 3rd Qtr result will be good and drive the share prices higher.

 

We shall see the financial results on nov 12.. it will be interesting..

 

Can't see from my side as well..

starlene      ( Date: 01-Nov-2013 22:56) Posted: Who is elling or buying Biosensor,,,my laptop can't open..some kind soul can help..thks a million   http://infopub.sgx.com/FileOpen/FORM3_Atlantis_29Oct13.ashx?App=Announcement& FileID=262344  New123      ( Date: 01-Nov-2013 20:17) Posted: BioFreedom? Continues to Demonstrate Comparable Long - Term Safety and Efficacy to Conventional DES   BioFreedom is in the process of being launched in selected markets, with a full commercial launch anticipated during 2014.   hopefully 3rd Qtr result will be good and drive the share prices higher.

 

Who is elling or buying Biosensor,,,my laptop can't open..some kind soul can help..thks a million

 

http://infopub.sgx.com/FileOpen/FORM3_Atlantis_29Oct13.ashx?App=Announcement& FileID=262344 

New123      ( Date: 01-Nov-2013 20:17) Posted: BioFreedom? Continues to Demonstrate Comparable Long - Term Safety and Efficacy to Conventional DES   BioFreedom is in the process of being launched in selected markets, with a full commercial launch anticipated during 2014.   hopefully 3rd Qtr result will be good and drive the share prices higher.

 

Lewfys..hi fyi I sold off when UOB Kayhian issued a report that T.P for Rex is $1.47..I sold off on this news

lewfys      ( Date: 01-Nov-2013 15:52) Posted: Ms Starlene, I thought you just loaded Rex between 79.5-80.5cts on 28th Oct for long haul purposes... So how did you manage to off load from 90-96cts?   starlene      ( Date: 01-Nov-2013 10:39) Posted: Ok ..can withstand the loss..that's why I bet using the surplus profit and not too worry..Oct 21 was the best year of my trade when the 3 designated stocks got lifted..I sold ..afdter going thru inconvenience of bringing cash nearly everyday to buy..I learnt from Jade case when it was designated buy when demand was artificallyy curbed and sell immediatedly when the stocks were lifted..enough profit for the year..was also lucky to off load all my maxi-cash at 42.5-43cts after ex bonus and all my mother Rowsley shares 35.5-38cts and Rex off loaded from 90-96cts..waiting for lower entryt level to go in agai

 

BioFreedom? Continues to Demonstrate Comparable Long - Term Safety and Efficacy to Conventional DES

 

 

Ms Starlene,

I thought you just loaded Rex between 79.5-80.5cts on 28th Oct for long haul purposes... So how did you manage to off load from 90-96cts?  

starlene      ( Date: 01-Nov-2013 10:39) Posted: Ok ..can withstand the loss..that's why I bet using the surplus profit and not too worry..Oct 21 was the best year of my trade when the 3 designated stocks got lifted..I sold ..afdter going thru inconvenience of bringing cash nearly everyday to buy..I learnt from Jade case when it was designated buy when demand was artificallyy curbed and sell immediatedly when the stocks were lifted..enough profit for the year..was also lucky to off load all my maxi-cash at 42.5-43cts after ex bonus and all my mother Rowsley shares 35.5-38cts and Rex off loaded from 90-96cts..waiting for lower entryt level to go in again yiming2000      ( Date: 01-Nov-2013 10:33) Posted: Friend Starlene, what's happening? Why is the floor falling beneath our feet? 6 cents drop for 100 lots is a loss of $6,000.     You are now stuck like me.

 

Yiming2000..safer to buy big cap stock..I am almost completely out of all pennies stock..other than the free rowsley  bonus warrants..bought F& N( 5 lots from $5.50 to 5.60)..giving 2 FCL shares for every 1 F& N shares ..I guess after the EGM in Nov 14..F& N may cross $6

 

Ok ..can withstand the loss..that's why I bet using the surplus profit and not too worry..Oct 21 was the best year of my trade when the 3 designated stocks got lifted..I sold ..afdter going thru inconvenience of bringing cash nearly everyday to buy..I learnt from Jade case when it was designated buy when demand was artificallyy curbed and sell immediatedly when the stocks were lifted..enough profit for the year..was also lucky to off load all my maxi-cash at 42.5-43cts after ex bonus and all my mother Rowsley shares 35.5-38cts and Rex off loaded from 90-96cts..waiting for lower entryt level to go in again

yiming2000      ( Date: 01-Nov-2013 10:33) Posted: Friend Starlene, what's happening? Why is the floor falling beneath our feet? 6 cents drop for 100 lots is a loss of $6,000.     You are now stuck like me.

 

Friend Starlene, what's happening? Why is the floor falling beneath our feet? 6 cents drop for 100 lots is a loss of $6,000.

 

 

You are now stuck like me. 

 

Nope, only short term tech rebound at best. The chart stinks.

MAs, Stochs, RSI, Directional Movement indicators all pointing towards pullback.

 

BIG  shares-buy back today?

 

Slowly climbed up from 0.80+ to 1, braving through quite a few market sell down. But once everybody's attention is back on it, it starts to come out with such stunt, jialat

 

why tdy dropped so much? may be the comp didn't buy back shares?

hv to bounce off from 94 cents, if not, may go down to 90 cents.

 

Dropped everyday! ! The one-lot i-seller works very hard..

 

Oh no : ( close below 1..

 

TCT: Are Dissolving Scaffolds a True Advance?

Published: Oct 28, 2013

http://www.medpagetoday.com/MeetingCoverage/TCT/42514

I believe biosensor's stents safe from the challenge posed by absorbable scaffold for the next 5 years. By then  Biosensors should have their answer to the absorbable scaffold -

 

Results of the SORT-OUT VI Trial Presented at TCT 2013  

SAN FRANCISCO, CA.   A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention (PCI). The findings of the SORT-OUT VI trial were presented today at the 25^th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world?s premier educational meeting specializing in interventional cardiovascular medicine.

Compared with bare metal stents, first generation DES reduced the risk of restenosis. However, the risk of stent thrombosis was a concern and newer generation DES have been designed to improve efficacy, safety, and device performance. To date, there are no large scale randomized comparison studies of biodegradable polymer-coated stents and biocompatible polymer-coated stents in all-comer populations. The SORT-OUT VI trial investigated the safety and efficacy of a durable but biocompatible polymer coated zotarolimus-eluting stent compared with a biodegradable polymer-coated biolimus-eluting stent in a population-based setting.

SORT-OUT VI was a multicenter, all-comer, non-inferiority trial that randomized 2,999 patients with stable coronary artery disease or acute coronary syndromes. The trial was performed within the framework of the Scandinavian Organization for Randomized Trials with Clinical Outcomes, and used patient-driven clinical event detection through Danish health care registries.

Patients were randomized to receive either a zotarolimus-eluting permanent polymer stent (n=1,502) or a biolimus-eluting biodegradable stent (n=1,497). The primary endpoint was a composite of major adverse cardiac events including cardiac death, myocardial infarction,                and target lesion revascularization after 12 months.    

After 12 months the percentage of patients with major adverse cardiac events was similarly low in both the zotarolimus-eluting and biolimus-eluting stent groups (5.3 percent and 5.1 percent, respectively), demonstrating the non-inferiority of the zotarolimus-eluting stent.

?The SORT OUT VI trial found that both zotarolimus-eluting and the biolimus-eluting stents were associated with low major adverse cardiac events,? said lead investigator Bent Raungaard MD. Dr. Raungaard is Chief Physician and Associate Professor at Aalborg University Hospital in Denmark.

?Further, the zotarolimus-eluting stent was found to be non-inferior to the biolimus-eluting stent for patients treated with PCI.?

The SORT OUT VI trial was supported by unrestricted grants from Biosensors Interventional Technologies Pte Ltd. and Medtronic CardioVascular, Inc. Dr. Raungaard reported no disclosures.

The results of the SORT-OUT VI trial will be presented on Tuesday, October 29 at 11:25 AM PDT in the Main Arena (Moscone South, Esplanade Ballroom) of The Moscone Center.

Source: The Cardiovascular Research Foundation

topdog22      ( Date: 30-Oct-2013 08:54) Posted: Thank you for the reference.  Are more results expected tomorrow? As I stated, technically BIG's products are very good BUT management leaves much to be desired!! Any thoughts on when the technical superiority will be reflected in the share price?

 

Thank you for the reference.  Are more results expected tomorrow?

As I stated, technically BIG's products are very good BUT management leaves much to be desired!!

Any thoughts on when the technical superiority will be reflected in the share price?